FDA’s Fall Regulatory Agenda Adds Several New Proposed and Final Rules Post author:PacConAdmin Post published:December 19, 2021 Post category:Drug Industry Daily The FDA’s fall 2021 regulatory agenda includes several new proposed and final rules. Source: Drug Industry Daily You Might Also Like Gilead Loses PTAB Patent Challenges February 21, 2020 ANDAs Must Demonstrate “Sameness” of Active Ingredients, FDA Draft Guidance Says November 8, 2022 Jazz Pharma Sues FDA, Claiming Approval of Avadel’s Narcolepsy Drug is Unlawful June 23, 2023